Millennium Management
BCLI

Millennium Management’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Millennium Management’s Portfolio BCLI Stock Details BCLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,700
Closed -$35.1K – 6089
2023
Q3 		$35.1K Buy
11,700
+2,527
+28% +$57.5K ﹤0.01% 5548
2023
Q2 		$283K Buy
9,173
+8,425
+1,126% +$349K ﹤0.01% 4923
2023
Q1 		$37K Sell
748
-2,027
-73% -$58.8K ﹤0.01% 5714
2022
Q4 		$68K Sell
2,775
-6,782
-71% -$254K ﹤0.01% 5696
2022
Q3 		$634K Buy
9,557
+2,224
+30% +$112K ﹤0.01% 4744
2022
Q2 		$304K Sell
7,333
-2,084
-22% -$93.8K ﹤0.01% 5344
2022
Q1 		$475K Sell
9,417
-594
-6% -$29.2K ﹤0.01% 5164
2021
Q4 		$601K Sell
10,011
-11
-0.1% -$541 ﹤0.01% 4884
2021
Q3 		$496K Sell
10,022
-14,742
-60% -$776K ﹤0.01% 5354
2021
Q2 		$1.41M Buy
+24,764
New +$1.32M ﹤0.01% 4322
2021
Q1 		– Sell
-3,511
Closed -$238K – 5907
2020
Q4 		$238K Buy
+3,511
New +$478K ﹤0.01% 4706
2020
Q3 		– Sell
-958
Closed -$161K – 4444
2020
Q2 		$161K Sell
958
-12,245
-93% -$1.32M ﹤0.01% 3895
2020
Q1 		$919K Buy
+13,203
New +$1.03M ﹤0.01% 2517

Other funds holding BCLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LWM
Liberty Wealth Management Oakland, California $800M AUM 20.44% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return
AHB
Abner Herrman & Brock Jersey City, New Jersey $1.05B AUM 42.66% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Millennium Management's BCLI Position: Q4 2023 in Review

Millennium Management sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q4 2023, closing a stake of 11,700 shares — an estimated $35.1K sold.

Millennium Management first reported a position in BCLI in Q1 2020 and held it in 13 quarters. The position peaked at $1.41M in Q2 2021. 46 funds tracked by Wall St. Rank hold BCLI as of Q4 2023.

  • Millennium Management reported no remaining BRAINSTORM CELL THERAPUTC position as of Q4 2023 after selling out during the quarter.
  • Millennium Management sold 11,700 BRAINSTORM CELL THERAPUTC shares in Q4 2023, an estimated $35.1K.
  • Millennium Management first reported a position in BRAINSTORM CELL THERAPUTC in Q1 2020 and held it in 13 quarters.
  • Millennium Management's BRAINSTORM CELL THERAPUTC position peaked at $1.41M in Q2 2021.
  • 46 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.